Corvus Pharmaceuticals (CRVS) Net Equity Issued and Repurchased (2015 - 2026)
Corvus Pharmaceuticals (CRVS) posted quarterly Net Equity Issued and Repurchased of $189.4 million for Q1 2026, up 492.1% quarter-over-quarter from $32.0 million in Q1 2021.
Analysis
Corvus Pharmaceuticals (CRVS) Net Equity Issued and Repurchased (2015 - 2026) Analysis & Trends
Corvus Pharmaceuticals' Net Equity Issued and Repurchased history runs 6 years deep, the most recent figure standing at $189.4 million for Q1 2026.
- In Q1 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $189.4 million; the TTM figure through Mar 2026 stood at $189.4 million (changed N/A YoY), while the FY2025 annual figure was $100.0 million, up 509.57% from the prior year.
- Net Equity Issued and Repurchased for Q1 2026 stood at $189.4 million, up from $32.0 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $189.4 million in Q1 2026, with the low at $189.4 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | 141.90 Mn |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | Corvus Pharmaceuticals | 1.33 Bn | 1.12 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 189.41 Mn |
| Mar 31, 2021 | 31.99 Mn |
| Dec 31, 2020 | 1.20 Mn |
| Jun 30, 2018 | -23,000.00 |
| Mar 31, 2018 | 64.90 Mn |
| Dec 31, 2016 | -1,000.00 |
| Jun 30, 2016 | 7.01 Mn |
| Mar 31, 2016 | 64.34 Mn |
| Sep 30, 2015 | 74.84 Mn |
| Jun 30, 2015 | 16.70 Mn |
| Mar 31, 2015 | 4.00 Mn |